Advertisement

Advertisement

ANEB Stock Latest News

Anebulo Pharmaceuticals Announces Voluntary Nasdaq Delisting Plan

Company AnnouncementsAnebulo Pharmaceuticals Announces Voluntary Nasdaq Delisting Plan

Anebulo Pharmaceuticals to voluntarily delist from Nasdaq

PremiumThe Fly

Anebulo Pharmaceuticals to voluntarily delist from Nasdaq

2M ago

Anebulo Pharmaceuticals Completes Oversubscribed Share Repurchase Tender

PremiumCompany Announcements

Anebulo Pharmaceuticals Completes Oversubscribed Share Repurchase Tender

2M ago

Anebulo Pharmaceuticals Announces Oversubscribed Self-Tender Offer Results

PremiumCompany Announcements

Anebulo Pharmaceuticals Announces Oversubscribed Self-Tender Offer Results

2M ago

Anebulo Pharmaceuticals Launches Self-Tender Offer to Go Private

PremiumCompany Announcements

Anebulo Pharmaceuticals Launches Self-Tender Offer to Go Private

3M ago

Anebulo announces cash tender offer of 300,000 shares at $3.50 per share

PremiumThe FlyAnebulo announces cash tender offer of 300,000 shares at $3.50 per share

3M ago

Anebulo Pharmaceuticals Reports Q1 2026 Financial Results

Company Announcements

Anebulo Pharmaceuticals Reports Q1 2026 Financial Results

4M ago

Anebulo Pharmaceuticals reports Q1 EPS (5c), one estimate (12c)

The Fly

Anebulo Pharmaceuticals reports Q1 EPS (5c), one estimate (12c)

4M ago

Anebulo Pharmaceuticals’ Selonabant Study: Key Insights for Investors

PremiumCompany Announcements

Anebulo Pharmaceuticals’ Selonabant Study: Key Insights for Investors

5M ago

Anebulo Pharmaceuticals’ Bold Move: Potential Risks of Going Private with Reverse Stock Split

PremiumCompany Announcements

Anebulo Pharmaceuticals’ Bold Move: Potential Risks of Going Private with Reverse Stock Split

6M ago

Anebulo Pharmaceuticals Advances Cannabis Toxicity Treatment

PremiumCompany Announcements

Anebulo Pharmaceuticals Advances Cannabis Toxicity Treatment

6M ago

Anebulo Pharmaceuticals doses first subjects in selonabant study

PremiumThe Fly

Anebulo Pharmaceuticals doses first subjects in selonabant study

6M ago

ANEB Earnings this Week: How Will it Perform?

PremiumPre-EarningsANEB Earnings this Week: How Will it Perform?

6M ago

Anebulo Pharmaceuticals Explores Strategic Alternatives Update

Company Announcements

Anebulo Pharmaceuticals Explores Strategic Alternatives Update

6M ago

Anebulo Pharmaceuticals provides update on going private transaction

The Fly

Anebulo Pharmaceuticals provides update on going private transaction

6M ago

Anebulo Pharmaceuticals downgraded to Hold from Buy at Maxim

PremiumThe Fly

Anebulo Pharmaceuticals downgraded to Hold from Buy at Maxim

8M ago

Anebulo Pharmaceuticals Announces Plan to Go Private

PremiumCompany Announcements

Anebulo Pharmaceuticals Announces Plan to Go Private

8M ago

Anebulo Pharmaceuticals price target lowered to $3 from $6 at Maxim

PremiumThe Fly

Anebulo Pharmaceuticals price target lowered to $3 from $6 at Maxim

10M ago

Anebulo Pharmaceuticals Focuses on Pediatric Cannabis Toxicity Treatment

PremiumCompany Announcements

Anebulo Pharmaceuticals Focuses on Pediatric Cannabis Toxicity Treatment

10M ago

Anebulo Pharmaceuticals files to sell 15.15M shares of common stock for holders

PremiumThe FlyAnebulo Pharmaceuticals files to sell 15.15M shares of common stock for holders

1y ago

Anebulo Pharmaceuticals Reports Fiscal Q2 2025 Results

Company Announcements

Anebulo Pharmaceuticals Reports Fiscal Q2 2025 Results

1y ago

Anebulo Pharmaceuticals reports Q4 EPS (9c) vs. (11c) last year

The Fly

Anebulo Pharmaceuticals reports Q4 EPS (9c) vs. (11c) last year

1y ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >